Work

Exciting New Targets in Lung Cancer Therapy: ALK, IGF-1R, HDAC, and Hh

Year: 2010

Type: article

Source: Current Treatment Options in Oncology

DOI: 10.1007/s11864-010-0120-6

Authors: Joel W. Neal, Lecia V. Sequist

Institutions: Stanford Medicine, Stanford Cancer Institute, Stanford University, Massachusetts General Hospital

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1976447570

FWCI: 6.395

Cites: 57

Cited by: 53

Related to: 10